Role of Intralesional Antibiotic for Treatment of Subretinal Abscess - Case Report and Literature Review.
41-gauge injection
Endogenous endophthalmitis
citrobacter
intralesional injection
piperacillin
subretinal abscess
tazobactam
Journal
Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169
Informations de publication
Date de publication:
17 Feb 2022
17 Feb 2022
Historique:
pubmed:
19
9
2020
medline:
23
4
2022
entrez:
18
9
2020
Statut:
ppublish
Résumé
To describe a rare case of endogenous endophthalmitis due to Citrobacter with subretinal abscess and the role of the novel technique of intralesional antibiotic for its treatment. A retrospective case report. A 45-year-old male presenting with painful, progressive diminution of vision in the left eye was diagnosed to have endogenous endophthalmitis due to Citrobacter with subretinal abscess. After the failure of the initial intravitreal injection of ceftazidime and vancomycin, successful resolution of abscess was achieved by pars plana vitrectomy with 41-gauge (G) needle assisted intralesional injection of piperacillin and tazobactam combination. We treated a case of Citrobacter associated endogenous endophthalmitis with subretinal abscess with intralesional injection of piperacillin and tazobactam combination. 41-G needle can be used safely to inject antibiotic into the subretinal space through a small self-sealing retinotomy with minimum risk of retinal detachment and encouraging results.
Identifiants
pubmed: 32946306
doi: 10.1080/09273948.2020.1811880
doi:
Substances chimiques
Anti-Bacterial Agents
0
Tazobactam
SE10G96M8W
Piperacillin
X00B0D5O0E
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM